300 related articles for article (PubMed ID: 10803738)
1. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
2. THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivo.
Papadopoulou MV; Ji M; Bloomer WD
In Vivo; 1996; 10(1):49-57. PubMed ID: 8726811
[TBL] [Abstract][Full Text] [Related]
3. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as chemosensitizer: mechanistic studies. II.
Papadopoulou MV; Rosenzweig HS; Ji M; Khan SH; Bloomer WD
Oncol Res; 1998; 10(3):163-73. PubMed ID: 9700727
[TBL] [Abstract][Full Text] [Related]
4. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
5. DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents.
Papadopoulou MV; Bloomer WD
In Vivo; 2007; 21(2):175-80. PubMed ID: 17436565
[TBL] [Abstract][Full Text] [Related]
6. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 1997; 9(5):249-57. PubMed ID: 9306432
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the potentiation of paclitaxel or 5-fU by the hypoxic cytotoxin NLCQ-1 (NSC 709257) in vitro.
Papadopoulou MV; Ji X; Bloomer WD
Anticancer Res; 2005; 25(3B):2161-70. PubMed ID: 16158959
[TBL] [Abstract][Full Text] [Related]
8. THNLA-1 as radio/chemosensitiser of EMT-6 tumours in mice.
Papadopoulou MV; Ji M; Bloomer WD
Br J Cancer Suppl; 1996 Jul; 27():S267-70. PubMed ID: 8763895
[TBL] [Abstract][Full Text] [Related]
9. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
Roizin-Towle L
J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
12. Intercellular transfer of drug resistance.
Frankfurt OS; Seckinger D; Sugarbaker EV
Cancer Res; 1991 Feb; 51(4):1190-5. PubMed ID: 1997161
[TBL] [Abstract][Full Text] [Related]
13. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
14. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
15. Repair of chromatin damage in glutathione-depleted V-79 cells: comparison of oxic and hypoxic conditions.
Xue LY; Friedman LR; Oleinick NL
Radiat Res; 1988 Oct; 116(1):89-99. PubMed ID: 3186930
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
17. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
Ducore JM; McNamara L
Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
Frankfurt OS; Seckinger D; Sugarbaker EV
Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA
Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511
[TBL] [Abstract][Full Text] [Related]
20. Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay.
Donnelly ET; Liu Y; Paul TK; Rockwell S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1176-86. PubMed ID: 15990023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
